A rapid CRISPR competitive assay for in vitro and in vivo discovery of potential drug targets affecting the hematopoietic system
CRISPR/Cas9 can be used as an experimental tool to inactivate genes in cells. However, a CRISPR-targeted cell population will not show a uniform genotype of the targeted gene. Instead, a mix of genotypes is generated - from wild type to different forms of insertions and deletions. Such mixed genotyp...
Saved in:
Main Authors: | Shen, Yunbing, Jiang, Long, Iyer, Vaishnavi Srinivasan, Raposo, Bruno, Dubnovitsky, Anatoly, Boddul, Sanjaykumar V., Kasza, Zsolt, Wermeling, Fredrik |
---|---|
Other Authors: | School of Physical and Mathematical Sciences |
Format: | Article |
Language: | English |
Published: |
2021
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/153758 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Genome editing in mammalian cell lines using CRISPR-Cas
by: Liu, Ivy Kaiwen, et al.
Published: (2021) -
RNA interference in the age of CRISPR: Will CRISPR interfere with RNAI?
by: Unniyampurath, U, et al.
Published: (2020) -
Designing custom CRISPR libraries for hypothesis-driven drug target discovery
by: Iyer, Vaishnavi Srinivasan, et al.
Published: (2021) -
CRISPR/Cas9-induced DNA damage enriches for mutations in a p53-linked interactome: implications for CRISPR-based therapies
by: Jiang, Long, et al.
Published: (2022) -
Of mice and CRISPR: The post-CRISPR future of the mouse as a model system for the human condition
by: Liu, E.T, et al.
Published: (2020)